AmSurg CEO Christopher Holden Sells 5k Shares

On Sept. 9, Christopher Holden, CEO of ambulatory surgery center management and development company AmSurg, sold 5,000 shares of the company’s stock, according to a WKRB News & Analysis report.

Advertisement

The transaction, legally disclosed through the Securities & Exchange Commission, was a total of $187,800. The shares were sold for an average price of $37.56 each.

More Articles on Transactions and Valuation Issues:
Ambulatory Surgery Centers, Urgent Care Centers & Others: Where Do Ancillary Services Stand in the Race for Consolidation?
How Does Payer Mix Vary by Surgery Center Revenue? 18 Statistics
UCLA Health Sells Outpatient Surgery Center, Medical Building for $54M

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.